View Item 

Show simple item record

Racial and Gender Trends in the Use of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries Between 1997 and 2003
dc.contributor.authorChan, Paul S.en_US
dc.contributor.authorBirkmeyer, John D.en_US
dc.contributor.authorKrumholz, Harlan M.en_US
dc.contributor.authorSpertus, John A.en_US
dc.contributor.authorNallamothu, Brahmajee K.en_US
dc.date.accessioned2010-06-01T18:14:21Z
dc.date.available2010-06-01T18:14:21Z
dc.date.issued2009-03en_US
dc.identifier.citationChan, Paul S.; Birkmeyer, John D.; Krumholz, Harlan M.; Spertus, John A.; Nallamothu, Brahmajee K. (2009). "Racial and Gender Trends in the Use of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries Between 1997 and 2003." Congestive Heart Failure 15(2): 51-57. <http://hdl.handle.net/2027.42/71450>en_US
dc.identifier.issn1527-5299en_US
dc.identifier.issn1751-7133en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71450
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19379450&dopt=citationen_US
dc.format.extent215036 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights© 2009 Wiley Periodicals, Inc.en_US
dc.titleRacial and Gender Trends in the Use of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries Between 1997 and 2003en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumthe Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI;en_US
dc.contributor.affiliationumthe Division of Cardiology, VA Ann Arbor Health Services Research & Development Center of Excellence and the University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherFrom the Department of Cardiovascular Research, Mid-America Heart Institute and the University of Missouri-Kansas City, Kansas City, MO;en_US
dc.contributor.affiliationotherthe Section of Cardiovascular Medicine and the Center for Outcomes Research and Evaluation, Yale University School of Medicine and Yale New Haven Hospital, New Haven, CTen_US
dc.identifier.pmid19379450en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71450/1/j.1751-7133.2009.00060.x.pdf
dc.identifier.doi10.1111/j.1751-7133.2009.00060.xen_US
dc.identifier.sourceCongestive Heart Failureen_US
dc.identifier.citedreferenceMoss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933 – 1940.en_US
dc.identifier.citedreferenceMoss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction. N Engl J Med. 2002; 346: 877 – 883.en_US
dc.identifier.citedreferenceBardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225 – 237.en_US
dc.identifier.citedreferenceBuxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882 – 1890.en_US
dc.identifier.citedreference5 A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997; 337: 1576 – 1583.en_US
dc.identifier.citedreferenceConnolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297 – 1302.en_US
dc.identifier.citedreferenceChan PS, Chow T, Kereiakes D, et al. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction. Arch Intern Med 2006; 166: 2228 – 2233.en_US
dc.identifier.citedreferenceChan PS, Hayward RA. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study. J Am Coll Cardiol 2005; 45: 1474 – 1481.en_US
dc.identifier.citedreferenceSanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005; 353: 1471 – 1480.en_US
dc.identifier.citedreferenceAl-Khatib SM, Anstrom KJ, Eisenstein EL, et al. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med 2005; 142: 593 – 600.en_US
dc.identifier.citedreferenceVoigt A, Ezzeddine R, Barrington W, et al. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol 2004; 44: 855 – 858.en_US
dc.identifier.citedreferenceEscarce JJ, Epstein KR, Colby DC, et al. Racial differences in the elderly’s use of medical procedures and diagnostic tests. Am J Public Health 1993; 83: 948 – 954.en_US
dc.identifier.citedreferenceVaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 2005; 353: 671 – 682.en_US
dc.identifier.citedreferenceKressin NR, Petersen LA. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med 2001; 135: 352 – 366.en_US
dc.identifier.citedreferenceJha AK, Fisher ES, Li Z, et al. Racial trends in the use of major procedures among the elderly. N Engl J Med 2005; 353: 683 – 691.en_US
dc.identifier.citedreferenceSchneider EC, Leape LL, Weissman JS, et al. Racial differences in cardiac revascularization rates: does “overuse” explain higher rates among white patients? Ann Intern Med 2001; 135: 328 – 337.en_US
dc.identifier.citedreferenceGauri AJ, Davis A, Hong T, et al. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med 2006; 119: e17 – e21.en_US
dc.identifier.citedreferenceEpstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse? N Engl J Med 2000; 343: 1537 – 1544, 1532 p preceding 1537.en_US
dc.identifier.citedreferenceCanto JG, Allison JJ, Kiefe CI, et al. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med 2000; 342: 1094 – 1100.en_US
dc.identifier.citedreferenceRothman K, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven Publishers; 1998: 260 – 262.en_US
dc.identifier.citedreferenceGroeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol 2005; 45: 72 – 78.en_US
dc.identifier.citedreferenceHernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 2007; 298: 1525 – 1532.en_US
dc.identifier.citedreferenceRathore SS, Krumholz HM. Differences, disparities, and biases: clarifying racial variations in health care use. Ann Intern Med 2004; 141: 635 – 638.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1751-7133.2009.00060.x.pdf
Size:
209.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.